Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

United Health Products (UEEC) Long-Term Investments (2020 - 2024)

United Health Products' Long-Term Investments history spans 5 years, with the latest figure at $25.3 million for Q2 2024.

  • Quarterly results put Long-Term Investments at $25.3 million for Q2 2024, changed 0.0% from a year ago — trailing twelve months through Jun 2024 was $25.3 million (changed 0.0% YoY), and the annual figure for FY2022 was $25.3 million, down 6.31%.
  • Long-Term Investments for Q2 2024 was $25.3 million at United Health Products, roughly flat from $25.3 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $27.0 million in Q4 2021 to a low of $43120.0 in Q4 2020.
  • The 5-year median for Long-Term Investments is $25.3 million (2022), against an average of $20.3 million.
  • The sharpest move saw Long-Term Investments surged 62555.84% in 2021, then fell 6.31% in 2022.
  • Year by year, Long-Term Investments stood at $43120.0 in 2020, then surged by 62555.84% to $27.0 million in 2021, then dropped by 6.31% to $25.3 million in 2022, then changed by 0.0% to $25.3 million in 2023, then changed by 0.0% to $25.3 million in 2024.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $25.3 million, $25.3 million, and $25.3 million for Q2 2024, Q1 2024, and Q3 2023 respectively.